Cargando…

Correction: Stalder, et al.; Value of SUV(max) for the Prediction of Bone Invasion in Oral Squamous Cell Carcinoma. Biology 2020, 9, 23

Detalles Bibliográficos
Autores principales:	Stalder, Stephanie A., Schumann, Paul, Lanzer, Martin, Hüllner, Martin W., Rupp, Niels J., Broglie, Martina A., Morand, Grégoire B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344941/ https://www.ncbi.nlm.nih.gov/pubmed/32485844 http://dx.doi.org/10.3390/biology9060113

Ejemplares similares

Value of SUV(max) for the Prediction of Bone Invasion in Oral Squamous Cell Carcinoma
por: Stalder, Stephanie A., et al.
Publicado: (2020)

Predictive Value of Pretherapeutic Maximum Standardized Uptake Value (Suv(max)) In Laryngeal and Hypopharyngeal Cancer
por: Werner, Jonas, et al.
Publicado: (2019)

Predictive value of suvmax changes between two sequential post-therapeutic FDG-pet in head and neck squamous cell carcinomas
por: Stadler, Thomas M., et al.
Publicado: (2020)

Histometabolic Tumor Imaging of Hypoxia in Oral Cancer: Clinicopathological Correlation for Prediction of an Aggressive Phenotype
por: Morand, Grégoire B., et al.
Publicado: (2020)

Histopathological Analysis of Nodal Disease After Chemoradiation Reveals Viable Tumor Cells as the most Important Prognostic Factor in Head and Neck Squamous Cell Carcinoma
por: Golliez, Aline, et al.
Publicado: (2023)

Maximum Standardized Uptake Value (SUV(max)) of Primary Tumor Predicts Occult Neck Metastasis in Oral Cancer
por: Morand, Grégoire B., et al.
Publicado: (2018)

FDG PET using SUV(max) for preoperative T-staging of esophageal squamous cell carcinoma with and without neoadjuvant chemoradiotherapy
por: Huang, Yung-Cheng, et al.
Publicado: (2017)

Who’s Driving? Switch of Drivers in Immunotherapy-Treated Progressing Sinonasal Melanoma
por: Freiberger, Sandra N., et al.
Publicado: (2021)

Significance of SUV Max for Predicting Occult Lymph Node Metastasis and Prognosis in Early-Stage Tongue Squamous Cell Carcinoma
por: Xu, Chunmiao, et al.
Publicado: (2020)

Expanding the clinicopathological spectrum of TGFBR3‐PLAG1 rearranged salivary gland neoplasms with myoepithelial differentiation including evidence of high‐grade transformation
por: Rupp, Niels J., et al.
Publicado: (2021)

Combinational expression of tumor testis antigens NY-ESO-1, MAGE-A3, and MAGE-A4 predicts response to immunotherapy in mucosal melanoma patients
por: Freiberger, Sandra N., et al.
Publicado: (2022)

Correlation of (18)F-FDG/PET SUV(max), SUV(mean), MTV, and TLG with HIF-1α in Patients with Colorectal Cancer
por: Kaymak, Zümrüt Arda, et al.
Publicado: (2021)

SalvGlandDx – a comprehensive salivary gland neoplasm specific next generation sequencing panel to facilitate diagnosis and identify therapeutic targets
por: Freiberger, Sandra N., et al.
Publicado: (2021)

Morpho-Molecular Assessment Indicates New Prognostic Aspects and Personalized Therapeutic Options in Sinonasal Melanoma
por: Freiberger, Sandra N., et al.
Publicado: (2019)

Need for adjuvant radiotherapy in oral cancer: depth of invasion rather than tumor diameter
por: Riemenschnitter, Cosima E., et al.
Publicado: (2022)

Assessment of Mediastinal Tumors Using SUV(max) and Volumetric Parameters on FDG-PET/CT
por: Morita, Takahiro, et al.
Publicado: (2017)

Utility of SUV(max) on (18) F-FDG PET in detecting cervical nodal metastases
por: Lim, Rebecca S. M., et al.
Publicado: (2016)

Histopathological Analysis of Nodal Disease After Chemoradiation Reveals Viable Tumor Cells as the most Important Prognostic Factor in Head and Neck Squamous Cell Carcinoma, DOI 10.1007/s12105-023-01557-7
por: Morand, Grégoire B., et al.
Publicado: (2023)

A dataset on patient-individual lymph node involvement in oropharyngeal squamous cell carcinoma
por: Ludwig, Roman, et al.
Publicado: (2022)

Basic and clinical immunology – 3032. 18FDG-PET/CT findings (SUV-MAX) are correlated with survival in stage-4 squamous cell carcinoma
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Frequency and Localization of Second Primary Tumors in Patients with Oropharyngeal Carcinoma—The Influence of the Human Papilloma Virus
por: Bosshart, Salome L., et al.
Publicado: (2021)

Deformation Effect on SUV(max) Changes in Thoracic Tumors Using 4-D PET/CT Scan
por: Huang, Tzung-Chi, et al.
Publicado: (2013)

Pretreatment SUV(max) value to predict outcome in patients with stage III NSCLC receiving concurrent chemoradiotherapy
por: Yaprak, Gokhan, et al.
Publicado: (2019)

Prognostic Prediction of BRCA Mutations by (18)F-FDG PET/CT SUV(max) in Breast Cancer
por: Özdemir, Semra, et al.
Publicado: (2021)

The Impact of Primary Tumor and Locoregional Metastatic Lymph Node SUV(max) on Predicting Survival in Patients with Rectal Cancer
por: Alçın, Göksel, et al.
Publicado: (2020)

Congenital fistula of the fourth branchial arch: Report of case with long‐lasting misdiagnosis
por: Stadler, Thomas M., et al.
Publicado: (2019)

Prognostic value of SUV(max) in breast cancer and comparative analyses of molecular subtypes: A systematic review and meta-analysis
por: Lee, Moon il, et al.
Publicado: (2021)

Overall Neutrophil-to-Lymphocyte Ratio and SUV(max) of Nodal Metastases Predict Outcome in Head and Neck Cancer Before Chemoradiation
por: Werner, Jonas, et al.
Publicado: (2021)

Day 30 SUV(max) predicts progression in patients with lymphoma achieving PR/SD after CAR T-cell therapy
por: Al Zaki, Ajlan, et al.
Publicado: (2022)

SUV(max) reduction predicts long-term survival in patients of non-pCR both in the tumor and lymph nodes after neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma
por: Nagaki, Yushi, et al.
Publicado: (2021)

Early Changes of the Standardized Uptake Values (SUV(max)) Predict the Efficacy of Everolimus-Exemestane in Patients with Hormone Receptor-Positive Metastatic Breast Cancer
por: Sirico, Marianna, et al.
Publicado: (2020)

Is it safe to drive SUVs?
Publicado: (1998)

Prognostic value of nodal SUV(max) of (18)F-FDG PET/CT in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy
por: Lee, So Jung, et al.
Publicado: (2017)

Clinical impact of SUV(max) of interstitial lesions in lung cancer patients with interstitial lung disease who underwent pulmonary resection
por: Akaike, Kimitaka, et al.
Publicado: (2022)

Current knowledge on the sensitivity of the (68)Ga-somatostatin receptor positron emission tomography and the SUV(max) reference range for management of pancreatic neuroendocrine tumours
por: Virgolini, Irene, et al.
Publicado: (2016)

High Basal Maximal Standardized Uptake Value (SUV(max)) in Follicular Lymphoma Identifies Patients with a Low Risk of Long-Term Relapse
por: Assanto, Giovanni Manfredi, et al.
Publicado: (2021)

Improved diagnostic accuracy of hybrid positron emission tomography (PET) with tumor-specific radiotracer for head and neck squamous cell carcinoma staging
por: Morand, Grégoire B., et al.
Publicado: (2023)

Max Planck et les quanta
por: Boudenot, Jean-Claude, et al.
Publicado: (2016)

Pretreatment SUV(max) predicts progression-free survival in early-stage non-small cell lung cancer treated with stereotactic body radiation therapy
por: Horne, Zachary D, et al.
Publicado: (2014)

SUV3 Helicase and Mitochondrial Homeostasis
por: Chen, Phang-Lang
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vkilm8s6n87a0s2alr5bnlp91k